Related references
Note: Only part of the references are listed.Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians
Karl E. Anderson et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2021)
Targeted resequencing of FECH locus reveals that a novel deep intronic pathogenic variant and eQTLs may cause erythropoietic protoporphyria (EPP) through a methylation-dependent mechanism
Matteo Chiara et al.
GENETICS IN MEDICINE (2020)
Guidelines for Sanger sequencing and molecular assay monitoring
Beate M. Crossley et al.
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2020)
Protocol For Patients With Suspected Acute Porphyria
F. J. Castelbon Fernandez et al.
REVISTA CLINICA ESPANOLA (2020)
Molecular Analysis of 55 Spanish Patients with Acute Intermittent Porphyria
Maria-Jose Moran-Jimenez et al.
GENES (2020)
Updates on the diagnosis and management of the most common hereditary porphyrias: AIP and EPP
Michael Linenberger et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy
Paolo Ventura et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2020)
Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations
Yedidyah Weiss et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)
Herbert L. Bonkovsky et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Clinical Guide and Update on Porphyrias
Ulrich Stoelzel et al.
GASTROENTEROLOGY (2019)
International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias
Brenden Chen et al.
GENETICS IN MEDICINE (2019)
A next-generation-sequencing panel for mutational analysis of dominant acute hepatic porphyrias
Jasmin Barman-Aksozen et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2019)
Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations
Yedidyah Weiss et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Acute hepatic porphyrias: Identification of 46 hydroxymethylbilane synthase, 11 coproporphyrinogen oxidase, and 20 protoporphyrinogen oxidase novel mutations
Yonina Loskove et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes
Makiko Yasuda et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Acute Hepatic Porphyrias: Review and Recent Progress
Bruce Wang et al.
HEPATOLOGY COMMUNICATIONS (2019)
Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria
Chia-Ni Lin et al.
CLINICA CHIMICA ACTA (2018)
From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria
Hugo Lenglet et al.
HUMAN MOLECULAR GENETICS (2018)
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP)
Francesca Granata et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Development of bullous pemphigoid during the haemodialysis of a young man: case report and literature survey
Katarzyna Osipowicz et al.
INTERNATIONAL WOUND JOURNAL (2017)
Porphyria cutanea tarda: an intriguing genetic disease and marker
Nancy S. Handler et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)
Porphyria
D. Montgomery Bissell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mutation in human CLPX elevates levels of δ-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria
Yvette Y. Yien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Best practice guidelines on first-line laboratory testing for porphyria
Jacqueline Woolf et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria
V. Brancaleoni et al.
CLINICAL GENETICS (2016)
Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease
Brenden Chen et al.
HUMAN MUTATION (2016)
A method for determining δ-aminolevulinic acid synthase activity in homogenized cells and tissues
Hector A. Bergonia et al.
CLINICAL BIOCHEMISTRY (2015)
Haplotype Study in Argentinean Variegate Porphyria Patients
Barbara Xoana Granata et al.
HUMAN HEREDITY (2015)
Porphyrias: A 2015 update
Zoubida Karim et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Acute Intermittent Porphyria in Argentina: An Update
Gabriela Nora Cerbino et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis
Elena Di Pierro et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias
Paolo Ventura et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Pseudoporphyria induced by hemodialysis
Beata Bergler-Czop et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2014)
Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias
Siddesh Besur et al.
METABOLITES (2014)
Direct and simultaneous quantitation of 5-aminolaevulinic acid and porphobilinogen in human serum or plasma by hydrophilic interaction liquid chromatography-atmospheric pressure chemical ionization/tandem mass spectrometry
Christopher M. Benton et al.
BIOMEDICAL CHROMATOGRAPHY (2013)
Partial protoporphyrinogen oxidase (PPOX) gene deletions, due to different Alu-mediated mechanisms, identified by MLPA analysis in patients with variegate porphyria
Michela Barbaro et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Role of genetic testing in the management of patients with inherited porphyria and their families
S. D. Whatley et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2013)
Liquid chromatography and mass spectrometry of haem biosynthetic intermediates: a review
Christopher M. Benton et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
The porphyrias: advances in diagnosis and treatment
Manisha Balwani et al.
BLOOD (2012)
Extended haplotype studies in South African and Dutch variegate porphyria families carrying the recurrent p.R59W mutation confirm a common ancestry
A. M. van Tuyll van Serooskerken et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases
R. P. Katugampola et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Identification of an AluY-mediated deletion of exon 5 in the CPOX gene by MLPA analysis in patients with hereditary coproporphyria
M. Barbaro et al.
CLINICAL GENETICS (2012)
Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services
Mette C. Tollanes et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria
Jordi To-Figueras et al.
BLOOD (2011)
European Specialist Porphyria Laboratories: Diagnostic Strategies, Analytical Quality, Clinical Interpretation, and Reporting As Assessed by an External Quality Assurance Program
Aasne K. Aarsand et al.
CLINICAL CHEMISTRY (2011)
A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen
Jinglan Zhang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327R
Alev Hasanoglu et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Direct Assay of δ-Aminolevulinic Acid Dehydratase in Heme Biosynthesis for the Detection of Porphyrias by Tandem Mass Spectrometry
John R. Choiniere et al.
ANALYTICAL CHEMISTRY (2010)
Molecular epidemiology of erythropoietic protoporphyria in the UK
S. D. Whatley et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
The relevance of the individual genetic background for the toxicokinetics of two significant neurodevelopmental toxicants: Mercury and lead
Claudia Gundacker et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2010)
Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations
Irene Paradisi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Familial and Sporadic Porphyria Cutanea Tarda: Characterization and Diagnostic Strategies
Aasne K. Aarsand et al.
CLINICAL CHEMISTRY (2009)
Diagnostic Strategies for Autosomal Dominant Acute Porphyrias: Retrospective Analysis of 467 Unrelated Patients Referred for Mutational Analysis of the HMBS, CPOX, or PPOX Gene
Sharon D. Whatley et al.
CLINICAL CHEMISTRY (2009)
A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria
Chumei Li et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives
C. Badenas et al.
CLINICAL GENETICS (2009)
Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks
Eliane Sardh et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Multiplex ligation-dependent probe amplification: a novel approach for genetic diagnosis of Porphyria
Elena Di Pierro et al.
JOURNAL OF HUMAN GENETICS (2009)
C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload
Sharon D. Whatley et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Direct assay of enzymes in heme biosynthesis for the detection of porphyrias by tandem mass spectrometry. Porphobilinogen deaminase
Yuesong Wang et al.
ANALYTICAL CHEMISTRY (2008)
Direct assay of enzymes in heme biosynthesis for the detection of Porphyrias by tandem mass spectrometry. Uroporphyrinogen decarboxylase and coproporphyrinogen III oxidase
Yuesong Wang et al.
ANALYTICAL CHEMISTRY (2008)
A Simple and Rapid Fluorimetric Method for Simultaneous Determination of Protoporphyrin IX and Zinc Protoporphyrin IX in Whole Blood
Pei-Chen Zhou et al.
APPLIED SPECTROSCOPY (2008)
A 10376 bp deletion of FECH gene responsible for erythropoietic protoporphyria
Elena Di Pierro et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Automated imaging of circulating fluorocytes for the diagnosis of erythropoietic protoporphyria: a pilot study for population screening
Kin-Chong Lau et al.
JOURNAL OF MEDICAL SCREENING (2008)
Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria
Sharon D. Whatley et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Congenital erythropoietic porphyria due to a mutation in GATA1:: the first trans-acting mutation causative for a human porphyria
John D. Phillips et al.
BLOOD (2007)
Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion
Eliane Sardh et al.
CLINICAL PHARMACOKINETICS (2007)
Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria
E. Di Pierro et al.
CLINICAL GENETICS (2007)
Modern diagnosis and management of the porphyrias
Shigeru Sassa
BRITISH JOURNAL OF HAEMATOLOGY (2006)
A large deletion on chromosome 11 in acute intermittent porphyria
Elena Di Pierro et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Exonic deletions as a cause of erythropoietic protoporphyria
Lisa H. Wood et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2006)
Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion
Y Floderus et al.
CLINICAL CHEMISTRY (2006)
Estimation and application of biological variation of urinary δ-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria
AK Aarsand et al.
CLINICAL CHEMISTRY (2006)
A direct and simultaneous detection of zinc protoporphyrin IX, free protoporphyrin IX, and fluorescent heme degradation product in red blood cell hemolysates
QY Chen et al.
FREE RADICAL RESEARCH (2006)
Improvement in HPLC separation of porphyrin isomers and application to biochemical diagnosis of porphyrias
Pascale Macours et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria
L Gouya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Plasma fluorescence scanning did not detect latent variegate porphyria in nine patients with non-p.R59W mutations
CW Sies et al.
PATHOLOGY (2005)
Multiplex ligation-dependent probe amplification using a completely synthetic probe set
RF Stern et al.
BIOTECHNIQUES (2004)
A systematic study of the clinical and biochemical expression of variegate porphyria in a large South African family
RJ Hift et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Acute intermittent porphyria - Studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias
C Solis et al.
ARCHIVES OF NEUROLOGY (2004)
Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene
Y Floderus et al.
CLINICAL GENETICS (2002)
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
JP Schouten et al.
NUCLEIC ACIDS RESEARCH (2002)
Precision and accuracy of a HPLC method for measurement of fecal porphyrin concentrations
FMJ Zuijderhoudt et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)
Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients
XY Schneider-Yin et al.
HUMAN HEREDITY (2002)
δ-aminolevulinic acid dehydratase genotype and lead toxicity:: A HuGE review
SN Kelada et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
Front line tests for the investigation of suspected porphyria
AC Deacon et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
Homozygous variegate porphyria: 20 y follow-up and characterization of molecular defect
R Kauppinen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Non-erythroid form of acute intermittent porphyria caused by promoter and frameshift mutations distant from the coding sequence of exon 1 of the HMBS gene
SD Whatley et al.
HUMAN GENETICS (2000)
Share Paper
